Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
96358301000001119 | Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
96358401000001110 | Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) | Is a | Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) | Has active ingredient | Fluticasone | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) | Has specific active ingredient | Vilanterol | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) | Has specific active ingredient | Fluticasone furoate | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) | Has dispensed dose form | Conventional release powder for inhalation | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) | Has excipient | Excipient not declared | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) | Is a | Actual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) | Has manufactured dose form | Conventional release powder for inhalation | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) 30 dose | Has AMP | False | Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets